NCT05440656View on ClinicalTrials.gov

A Real World Study to Capture Clinical and Patient Centered Outcomes in Adults With Severe Eosinophilic Asthma Treated With Benralizumab.

CompletedOBSERVATIONAL
Enrollment

152

Participants

Timeline

Start Date

June 29, 2022

Primary Completion Date

April 13, 2025

Study Completion Date

April 13, 2025

Conditions
Severe Eosinophilic Asthma
Interventions
DRUG

Cohort

Participants with Severe Eosinophilic Asthma

Trial Locations (13)

11521

Research Site, Athens

11527

Research Site, Athens

12462

Research Site, Athens

15125

Research Site, Athens

17562

Research Site, Athens

26504

Research Site, Rio

45500

Research Site, Ioannina

49100

Research Site, Corfu

55535

Research Site, Thessaloniki

56429

Research Site, Thessaloniki

57010

Research Site, Thessaloniki

68100

Research Site, Alexandroupoli

71500

Research Site, Heraklion

Sponsors

Lead Sponsor

AstraZeneca
All Listed Sponsors
lead

AstraZeneca

INDUSTRY